ES2354452T3 - Reorganizaciones y mutaciones mitocondriales como herramientas de diganóstico para la detección de exposición solar, cáncer de próstata y otros cánceres. - Google Patents

Reorganizaciones y mutaciones mitocondriales como herramientas de diganóstico para la detección de exposición solar, cáncer de próstata y otros cánceres. Download PDF

Info

Publication number
ES2354452T3
ES2354452T3 ES06741413T ES06741413T ES2354452T3 ES 2354452 T3 ES2354452 T3 ES 2354452T3 ES 06741413 T ES06741413 T ES 06741413T ES 06741413 T ES06741413 T ES 06741413T ES 2354452 T3 ES2354452 T3 ES 2354452T3
Authority
ES
Spain
Prior art keywords
deletion
mtdna
mutations
prostate
pcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06741413T
Other languages
English (en)
Spanish (es)
Inventor
Robert Thayer
Ryan Parr
Gabriel Dakubo
Jennifer Maki
Andrea Aguirre
Mark Birch-Machin
Brian Reguly
Kerry Robinson
Andrew Harbottle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitomics Inc
Original Assignee
Mitomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitomics Inc filed Critical Mitomics Inc
Application granted granted Critical
Publication of ES2354452T3 publication Critical patent/ES2354452T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
ES06741413T 2005-04-18 2006-04-18 Reorganizaciones y mutaciones mitocondriales como herramientas de diganóstico para la detección de exposición solar, cáncer de próstata y otros cánceres. Expired - Lifetime ES2354452T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US67201605P 2005-04-18 2005-04-18
US672016P 2005-04-18
US72152205P 2005-09-29 2005-09-29
US721522P 2005-09-29
US78987206P 2006-04-07 2006-04-07
US789872P 2006-04-07
PCT/CA2006/000652 WO2006111029A1 (en) 2005-04-18 2006-04-18 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers

Publications (1)

Publication Number Publication Date
ES2354452T3 true ES2354452T3 (es) 2011-03-15

Family

ID=37114687

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06741413T Expired - Lifetime ES2354452T3 (es) 2005-04-18 2006-04-18 Reorganizaciones y mutaciones mitocondriales como herramientas de diganóstico para la detección de exposición solar, cáncer de próstata y otros cánceres.

Country Status (15)

Country Link
US (4) US8008008B2 (enExample)
EP (2) EP1877559B1 (enExample)
JP (2) JP5537804B2 (enExample)
KR (1) KR101363032B1 (enExample)
CN (2) CN101248180B (enExample)
AT (1) ATE484589T1 (enExample)
AU (1) AU2006238390B2 (enExample)
CA (2) CA2606156C (enExample)
DE (1) DE602006017534D1 (enExample)
DK (1) DK1877559T3 (enExample)
ES (1) ES2354452T3 (enExample)
NZ (2) NZ562928A (enExample)
PT (1) PT1877559E (enExample)
SG (1) SG2014011837A (enExample)
WO (1) WO2006111029A1 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130022979A1 (en) * 2005-04-18 2013-01-24 Genesis Genomics Inc. 3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
NZ562928A (en) * 2005-04-18 2011-01-28 Mitomics Inc Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
CN100526453C (zh) * 2005-05-20 2009-08-12 麦克奥迪实业集团有限公司 激光显微切割后细胞收集方法
US7919244B2 (en) * 2005-06-16 2011-04-05 Biotools Biotechnological & Medical Laboratories, S.A. Nucleic acid detection method involving the direct generation of a measurable signal
US20080254530A1 (en) * 2007-02-27 2008-10-16 Gettysburg College Isolation and characterization of a single mitochondrion
AU2007359381B2 (en) * 2007-09-26 2015-06-18 Mitomics Inc. 3.4 kb mitochondrial DNA deletion for use in the detection of cancer
AU2008310257B2 (en) * 2007-10-11 2013-12-05 Mdna Life Sciences Inc. Methods for assaying MC1R variants and mitochondrial markers in skin samples
WO2009046514A1 (en) * 2007-10-11 2009-04-16 Genesis Genomics Inc. Methods for non-invasive collection of skin cells for dna analysis
NZ584656A (en) * 2007-11-09 2012-08-31 Mitomics Inc Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer
NZ588658A (en) * 2008-03-28 2012-10-26 Mitomics Inc Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
JP2012501456A (ja) * 2008-08-28 2012-01-19 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
CA2735590A1 (en) * 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010048346A1 (en) 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2767833A3 (en) * 2008-10-21 2014-12-17 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN104330574B (zh) 2008-11-10 2017-04-12 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
EP2364370B1 (en) * 2008-11-22 2014-09-03 Astute Medical, Inc. Methods for prognosis of acute renal failure
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
RU2011137486A (ru) * 2009-03-27 2013-05-10 Митомикс Инк. Аберрантная митохондриальная днк, ассоциированные с ней слитые транскрипты, продукты трансляции и гибрадизационные зонды
EP2425240A4 (en) 2009-04-30 2012-12-12 Good Start Genetics Inc METHOD AND COMPOSITION FOR EVALUATING GENETIC MARKERS
US12129514B2 (en) 2009-04-30 2024-10-29 Molecular Loop Biosolutions, Llc Methods and compositions for evaluating genetic markers
KR20120061863A (ko) 2009-08-07 2012-06-13 아스튜트 메디컬 인코포레이티드 신장 손상 및 신부전증의 진단과 예후를 위한 방법 및 조성물
MX340078B (es) 2009-11-07 2016-06-24 Astute Medical Inc Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal.
JP2011115098A (ja) * 2009-12-04 2011-06-16 Nippon Menaade Keshohin Kk 加齢による皮膚明度の低下を予測する皮膚評価方法
MX342967B (es) 2009-12-20 2016-10-19 Astute Medical Inc Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
CN102791885B (zh) 2010-02-05 2015-09-09 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
EP2539712A4 (en) 2010-02-26 2013-09-18 Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
KR20190136107A (ko) * 2010-03-01 2019-12-09 엠디엔에이 라이프 사이언시즈 인코퍼레이티드 ＵＶ 관련된 ｍｔＤＮＡ 융합 전사체 및 이의 방법 및 용도
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2012MN02812A (enExample) 2010-06-23 2015-05-22 Astute Medical Inc
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
EP3246416B1 (en) 2011-04-15 2024-06-05 The Johns Hopkins University Safe sequencing system
EP2768983A4 (en) 2011-10-17 2015-06-03 Good Start Genetics Inc METHODS OF IDENTIFYING MUTATIONS ASSOCIATED WITH DISEASES
EP3540440B1 (en) 2011-12-08 2022-09-28 Astute Medical, Inc. Methods and uses for evaluating renal injury and renal status
US8209130B1 (en) * 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US8812422B2 (en) 2012-04-09 2014-08-19 Good Start Genetics, Inc. Variant database
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
AU2013292610B2 (en) * 2012-07-17 2018-05-17 Myriad Women's Health, Inc. System and methods for detecting genetic variation
WO2014070462A1 (en) 2012-10-29 2014-05-08 The Johns Hopkins University Papanicolaou test for ovarian and endometrial cancers
WO2014071178A1 (en) * 2012-11-05 2014-05-08 Icahn School Of Medicine At Mount Sinai Method of isolating pure mitochondrial dna
ES2482866B1 (es) * 2012-11-22 2015-05-12 Consejo Superior De Investigaciones Científicas (Csic) Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas.
JP6681195B2 (ja) 2013-01-17 2020-04-15 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
EP2971159B1 (en) 2013-03-14 2019-05-08 Molecular Loop Biosolutions, LLC Methods for analyzing nucleic acids
WO2014197377A2 (en) 2013-06-03 2014-12-11 Good Start Genetics, Inc. Methods and systems for storing sequence read data
US11041203B2 (en) 2013-10-18 2021-06-22 Molecular Loop Biosolutions, Inc. Methods for assessing a genomic region of a subject
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
US9745611B2 (en) * 2014-05-06 2017-08-29 Genewiz Inc. Methods and kits for identifying microorganisms in a sample
WO2015175530A1 (en) 2014-05-12 2015-11-19 Gore Athurva Methods for detecting aneuploidy
WO2015200905A2 (en) 2014-06-28 2015-12-30 Oligasis, Llc Dual pdgf/vegf antagonists
CN104062294A (zh) * 2014-07-11 2014-09-24 青岛千士医疗科技有限公司 一种支气管/肺上皮细胞线粒体损伤的检测方法
WO2016025818A1 (en) 2014-08-15 2016-02-18 Good Start Genetics, Inc. Systems and methods for genetic analysis
US11408024B2 (en) 2014-09-10 2022-08-09 Molecular Loop Biosciences, Inc. Methods for selectively suppressing non-target sequences
US10429399B2 (en) 2014-09-24 2019-10-01 Good Start Genetics, Inc. Process control for increased robustness of genetic assays
EP3207128B1 (en) 2014-10-17 2022-07-27 Kodiak Sciences Inc. Butyrylcholinesterase zwitterionic polymer conjugates
EP3271480B8 (en) 2015-01-06 2022-09-28 Molecular Loop Biosciences, Inc. Screening for structural variants
JP6929778B2 (ja) 2015-01-15 2021-09-01 グッド スタート ジェネティクス， インコーポレイテッド 着床前遺伝子スクリーニングにおける一塩基多型を用いた品質管理方法
EP3091083B1 (en) 2015-05-07 2017-11-08 Latvian Biomedical Research and Study Centre A kit for detecting mutation or polymorphism in the human mitochondrial dna
CN106338423B (zh) 2015-07-10 2020-07-14 三斯坎公司 组织学染色的空间复用
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
AU2017277305A1 (en) 2016-06-06 2018-12-20 Astute Medical, Inc. Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
KR20250047324A (ko) 2017-08-07 2025-04-03 더 존스 홉킨스 유니버시티 암을 평가하고 치료하기 위한 방법 및 재료
CN108827887B (zh) * 2018-03-19 2021-05-18 陕西学前师范学院 一种商陆基因组大小估计方法及基因组大小测量系统
EP3578671A1 (en) * 2018-06-05 2019-12-11 Universitat Autònoma De Barcelona Method for evaluating risk of cardiovascular disease
CN109360656B (zh) * 2018-08-20 2021-11-02 安徽大学 一种基于多目标演化算法的癌症检测方法
EP3966323A4 (en) * 2019-05-06 2024-04-24 The Regents Of The University Of Michigan Targeted therapy
CN110378881B (zh) * 2019-07-05 2020-03-24 北京航空航天大学 一种基于深度学习的肿瘤定位系统
CN110358856B (zh) * 2019-07-23 2023-04-07 四川省农业科学院生物技术核技术研究所 侧耳属线粒体nad4L基因的扩增引物及其在鉴定侧耳属物种中的应用
CN113025633B (zh) * 2019-12-09 2024-08-27 武汉纽福斯生物科技有限公司 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
WO2021163546A1 (en) 2020-02-14 2021-08-19 The Johns Hopkins University Methods and materials for assessing nucleic acids
US20230235400A1 (en) * 2020-06-04 2023-07-27 The General Hospital Corporation Methods of detecting mitochondrial diseases
CN117070511B (zh) * 2023-08-16 2024-02-02 广州卿泽生物科技有限公司 一种用于扩增人类线粒体全基因组的引物组及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2356536A (en) * 1939-07-18 1944-08-22 Rzymkowski Johannes Developing process
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US6027883A (en) 1994-03-30 2000-02-22 Mitokor Optimal procedure for isolation of mutant mitochondrial alleles
US5565323A (en) 1994-03-30 1996-10-15 Mitokor Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
EP0812922A3 (en) 1996-05-16 2002-08-21 Affymetrix, Inc. (a California Corporation) Polymorphisms in human mitochondrial nucleic acid
JP3251219B2 (ja) 1997-10-13 2002-01-28 雅嗣 田中 ヒトミトコンドリアｄｎａを用いた遺伝子検出方法
DE69914770T2 (de) 1998-08-20 2005-05-12 The Johns Hopkins University School Of Medicine Mitochondriale, als tumormarker geeignete mutationen, die nur ein basenpaar betreffen
US6605433B1 (en) 1998-08-20 2003-08-12 The Johns Hopkins University Mitochondrial dosimeter
US20020068277A1 (en) * 1998-11-20 2002-06-06 Simpson Andrew John George Method for determining nucleotide sequences using arbitrary primers and low stringency
JP2003521879A (ja) 1999-04-20 2003-07-22 マイトコー アルツハイマー病とともに分離するミトコンドリア遺伝子における一塩基多型
SE0003286D0 (sv) 2000-09-15 2000-09-15 Ulf Gyllensten Method and kit for human identification
US20030092019A1 (en) 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
JP2005506057A (ja) * 2001-06-11 2005-03-03 １３０４８５４ オンタリオ・リミテッド 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列
US20030162174A1 (en) 2001-06-11 2003-08-28 Sutherland John W. Detecting nucleic acid deletion sequences
US20050026167A1 (en) * 2001-06-11 2005-02-03 Mark Birch-Machin Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
US20040191769A1 (en) * 2001-07-24 2004-09-30 Transgenomic, Inc. Methods, compositions, and kits for mutation detection in mitochondrial DNA
CA2356536A1 (en) * 2001-08-30 2003-02-28 Emory University Mitochondrial dna sequence alleles
SE0200817D0 (sv) * 2002-03-15 2002-03-15 Ulf Gyllensten Method and kit for detection of mutations in mitochondrial DNA
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
NZ562928A (en) * 2005-04-18 2011-01-28 Mitomics Inc Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers

Also Published As

Publication number Publication date
KR20080025040A (ko) 2008-03-19
US10907213B2 (en) 2021-02-02
JP2012179053A (ja) 2012-09-20
NZ562928A (en) 2011-01-28
CA2606156A1 (en) 2006-10-26
JP2008536496A (ja) 2008-09-11
ATE484589T1 (de) 2010-10-15
CN103789405B (zh) 2018-03-30
EP1877559B1 (en) 2010-10-13
AU2006238390A1 (en) 2006-10-26
EP1877559A4 (en) 2009-06-10
US20090192047A1 (en) 2009-07-30
US20180105885A1 (en) 2018-04-19
SG2014011837A (en) 2014-04-28
WO2006111029A1 (en) 2006-10-26
EP1877559A1 (en) 2008-01-16
CA2606156C (en) 2013-01-08
PT1877559E (pt) 2011-01-19
KR101363032B1 (ko) 2014-02-13
NZ587665A (en) 2011-11-25
EP2339032B1 (en) 2016-12-28
AU2006238390B2 (en) 2011-07-28
JP5537804B2 (ja) 2014-07-02
CN101248180B (zh) 2013-09-25
CN103789405A (zh) 2014-05-14
DK1877559T3 (da) 2011-02-07
EP2339032A1 (en) 2011-06-29
US8008008B2 (en) 2011-08-30
US20150284805A1 (en) 2015-10-08
US20120058483A1 (en) 2012-03-08
US9745632B2 (en) 2017-08-29
JP6134890B2 (ja) 2017-05-31
CA2792443A1 (en) 2006-10-26
CN101248180A (zh) 2008-08-20
DE602006017534D1 (de) 2010-11-25

Similar Documents

Publication Publication Date Title
US10907213B2 (en) Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
US20050026167A1 (en) Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
Shyamsundar et al. Exome sequencing with validations and expression of p16/cdkn2a shows no association with HPV in oral cancers
US20070190534A1 (en) Mitochondrial sites and genes associated with prostate cancer
JP2005506057A (ja) 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列
AU2011242123B2 (en) Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
EP1694695A1 (en) Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
Bellido et al. Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency
HK1159190A (en) Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
HK1159190B (en) Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
Børsting et al. Mie Rath Refn, Mikkel Meyer Andersen, Marie‑Louise Kampmann, Jacob Tfelt‑Hansen, Erik Sørensen 4, Margit Hørup Larsen 4, Niels Morling
Ribeiro Gene promoter methylation-based biomarkers for early detection and monitoring of oral cancer
AU2002312671A1 (en) Complete mitochondrial genome sequences as a diagnostic tool for the health sciences